Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vogel

Showing results (211-220 of 693) with videos related to

Pageof 70
Sort By:
Menopause (New York, N.Y.)|August 14, 2008
Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancerVictor G Vogel
Clinical Interventions in Aging|March 14, 2009
Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifeneVictor G Vogel
Zeitschrift Fur Gerontologie|May 1, 1990
[Restitutio ad integrum of the mechanical properties of rat skin following repeated stretching. Effect of maturation and aging]H G Vogel
Biochimica Et Biophysica Acta|November 24, 1972
Influence of age, treatment with corticosteroids and strain rate on mechanical properties of rat skinH G Vogel
Evidence-Based Medicine|August 5, 2010
Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone)Victor G Vogel
Current Drug Targets|December 17, 2010
Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemopreventionVictor G Vogel
Breast Cancer (Dove Medical Press)|December 25, 2013
Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal womenVictor G Vogel
Cancer Prevention Research (Philadelphia, Pa.)|July 26, 2017
The Burdens and Uncertainties of Doing What One Should DoVictor G Vogel
Oncology (Williston Park, N.Y.)|October 1, 1996
Assessing women's potential risk of developing breast cancerV G Vogel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Can statin therapy reduce the risk of breast cancer?Victor G Vogel
Pageof 70

Showing results (211-220 of 693) with videos related to

Sort By:
Pageof 70
Menopause (New York, N.Y.)|August 14, 2008
Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancerVictor G Vogel
Clinical Interventions in Aging|March 14, 2009
Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifeneVictor G Vogel
Zeitschrift Fur Gerontologie|May 1, 1990
[Restitutio ad integrum of the mechanical properties of rat skin following repeated stretching. Effect of maturation and aging]H G Vogel
Biochimica Et Biophysica Acta|November 24, 1972
Influence of age, treatment with corticosteroids and strain rate on mechanical properties of rat skinH G Vogel
Evidence-Based Medicine|August 5, 2010
Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone)Victor G Vogel
Current Drug Targets|December 17, 2010
Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemopreventionVictor G Vogel
Breast Cancer (Dove Medical Press)|December 25, 2013
Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal womenVictor G Vogel
Cancer Prevention Research (Philadelphia, Pa.)|July 26, 2017
The Burdens and Uncertainties of Doing What One Should DoVictor G Vogel
Oncology (Williston Park, N.Y.)|October 1, 1996
Assessing women's potential risk of developing breast cancerV G Vogel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Can statin therapy reduce the risk of breast cancer?Victor G Vogel
Pageof 70